0001193125-20-107212.txt : 20200414 0001193125-20-107212.hdr.sgml : 20200414 20200414171540 ACCESSION NUMBER: 0001193125-20-107212 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200410 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant FILED AS OF DATE: 20200414 DATE AS OF CHANGE: 20200414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wave Life Sciences Ltd. CENTRAL INDEX KEY: 0001631574 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: U0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37627 FILM NUMBER: 20791930 BUSINESS ADDRESS: STREET 1: 7 STRAITS VIEW STREET 2: #12-00, MARINA ONE EAST TOWER CITY: SINGAPORE STATE: U0 ZIP: 018936 BUSINESS PHONE: 617-949-2900 MAIL ADDRESS: STREET 1: 733 CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 FORMER COMPANY: FORMER CONFORMED NAME: WAVE Life Sciences Ltd. DATE OF NAME CHANGE: 20170516 FORMER COMPANY: FORMER CONFORMED NAME: Wave Life Sciences Ltd. DATE OF NAME CHANGE: 20151106 FORMER COMPANY: FORMER CONFORMED NAME: Wave Life Sciences LTD. DATE OF NAME CHANGE: 20151106 8-K 1 d915389d8k.htm 8-K 8-K
00-0000000 false 0001631574 0001631574 2020-04-10 2020-04-10

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 10, 2020

 

WAVE LIFE SCIENCES LTD.

(Exact name of registrant as specified in its charter)

 

Singapore

  

001-37627

  

Not applicable

(State or other

jurisdiction of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

7 Straits View #12-00, Marina One East Tower

Singapore

  

018936

(Address of principal executive offices)

  

(Zip Code)

Registrant’s telephone number, including area code: +65 6236 3388

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

  

Trading

symbol

  

Name of each exchange

on which registered

$0 Par Value Ordinary Shares

  

WVE

  

The Nasdaq Global Market

 

 

ITEM 1.01 Entry Into a Material Definitive Agreement.

On April 8, 2020, Wave Life Sciences USA, Inc. (“Borrower”), a wholly owned subsidiary of Wave Life Sciences Ltd. (the “Company”), applied to JPMorgan Chase Bank, N.A. (“JPMorgan”) under the Small Business Administration (the “SBA”) Paycheck Protection Program of the Coronavirus Aid, Relief and Economic Security Act of 2020 (the “CARES Act”) for a loan of $7,234,890 (the “Loan”). On April 10, 2020, the Loan was approved and Borrower received the Loan proceeds, which Borrower plans to use for covered payroll costs, rent and utilities in accordance with the relevant terms and conditions of the CARES Act.

The Loan, which took the form of a promissory note issued by Borrower (the “Promissory Note”), has a two-year term, matures on April 8, 2022, and bears interest at a rate of 0.98% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (discussed below), will commence on November 8, 2020. Borrower did not provide any collateral or guarantees for the Loan, nor did Borrower pay any facility charge to obtain the Loan. The Promissory Note provides for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. Borrower may prepay the principal of the Loan at any time without incurring any prepayment charges.

The Loan may be forgiven partially or fully if the Loan proceeds are used for covered payroll costs, rent and utilities, provided that such amounts are incurred during the eight-week period that commenced on April 10, 2020 and at least 75% of any forgiven amount has been used for covered payroll costs. Any forgiveness of the Loan will be subject to approval by the SBA and JPMorgan and will require Borrower to apply for such treatment in the future.

ITEM 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure in Item 1.01 of this report is incorporated into this Item 2.03 by reference.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements concerning the Company’s expectations, anticipations, intentions, or beliefs regarding the Loan. These express or implied statements are not promises or guarantees and involve substantial risks and uncertainties. Among the factors that could cause actual results to differ materially from those described or projected herein are the following: financial market conditions; actions by the Loan parties; changes by the SBA or other governmental authorities regarding the CARES Act, the Payroll Protection Program or related administrative matters; and the Company’s and Borrower’s ability to comply with the terms of the Loan and the CARES Act, including to use the proceeds of the Loan as described herein. A further list and description of these risks, uncertainties and other risks associated with an investment in the Company can be found in Company’s filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K. The Company undertakes no obligation to update the information contained in this Current Report on Form 8-K to reflect subsequently occurring events or circumstances.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WAVE LIFE SCIENCES LTD.

     

By:

 

/s/ Paul B. Bolno, M.D.

 

Paul B. Bolno, M.D.

 

President and Chief Executive Officer

Date: April 14, 2020

EX-101.SCH 2 wve-20200410.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 wve-20200410_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Tax Identification Number Entity Tax Identification Number Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 4 wve-20200410_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE JSON 5 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d915389d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d915389d8k.htm" ] }, "labelLink": { "local": [ "wve-20200410_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "wve-20200410_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "wve-20200410.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "wve", "nsuri": "http://www.wavelifesciences.com/20200410", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d915389d8k.htm", "contextRef": "duration_2020-04-10_to_2020-04-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d915389d8k.htm", "contextRef": "duration_2020-04-10_to_2020-04-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.wavelifesciences.com//20200410/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d915389d8k.htm wve-20200410.xsd wve-20200410_lab.xml wve-20200410_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information
Apr. 10, 2020
Cover [Abstract]  
Entity Tax Identification Number 00-0000000
Amendment Flag false
Entity Central Index Key 0001631574
Document Type 8-K
Document Period End Date Apr. 10, 2020
Entity Registrant Name WAVE LIFE SCIENCES LTD.
Entity Incorporation State Country Code U0
Entity File Number 001-37627
Entity Address, Address Line One 7 Straits View #12-00
Entity Address, City or Town Marina One East Tower
Entity Address, Country SG
Entity Address, Postal Zip Code 018936
City Area Code +65
Local Phone Number 6236 3388
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Security 12b Title $0 Par Value Ordinary Shares
Trading Symbol WVE
Security Exchange Name NASDAQ

ZIP 12 0001193125-20-107212-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-107212-xbrl.zip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end XML 13 d915389d8k_htm.xml IDEA: XBRL DOCUMENT 0001631574 2020-04-10 2020-04-10 00-0000000 false 0001631574 8-K 2020-04-10 WAVE LIFE SCIENCES LTD. U0 001-37627 7 Straits View #12-00 Marina One East Tower SG 018936 +65 6236 3388 false false false false false $0 Par Value Ordinary Shares WVE NASDAQ